Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fredgoodwinsonon Nov 19, 2019 2:51pm

133 Views

Post# 30370648

RE:FDA

Thanks Blackjack - someone else here posted that the 30 days`commence once the to and fro is over -previous update from Amelia`s colleague was that the application was 'in process'.

Your further enquiry suggests that the Q & A is not current and in fact sufficiently historic for the Company to have cause to believe that it ended a while back.

If so that would be very good news.

Bullboard Posts

Questerre Energy applauds Québec tabling Bill 69